Ignite Creation Date:
2025-12-24 @ 6:29 PM
Ignite Modification Date:
2025-12-28 @ 2:11 AM
Study NCT ID:
NCT00142168
Status:
TERMINATED
Last Update Posted:
2016-04-21
First Post:
2005-09-01
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
CC-5013 (Lenalidomide) and Rituximab in Waldenstrom's Macroglobulinemia
Sponsor:
Dana-Farber Cancer Institute
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2004-09
Start Date Type:
None
Primary Completion Date:
2006-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2008-04
Completion Date Type:
ACTUAL
First Submit Date:
2005-09-01
First Submit QC Date:
None
Study First Post Date:
2005-09-02
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2012-12-19
Results First Submit QC Date:
None
Results First Post Date:
2015-12-16
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2016-03-23
Last Update Post Date:
2016-04-21
Last Update Post Date Type:
ESTIMATED